Short Summary/Abstract:
To assess psychosis as a multisystem disorder of accelerated aging, driven by inflammation and cellular stress. Using PsyShareD date, we will explore one of the core biomarkers of psychosis as a reduction in grey matter volume (GMV), cortical thinning and increasingly established evidence of advancing brain age in schizophrenia. BrainAge models demonstrate at least a 5-year gap between chronological age and predicted brain age compared to normative data, with reduced GMV focused in orbito-frontal and limbic areas. We will validate aging models across organs and systems in new well characterised psychosis cohort, with in-depth exploration of mechanisms and treatment targets.
Investigators & Affiliations: